Pterygoid Implants Market
The market for Pterygoid Implants was estimated at $84.4 million in 2025; it is anticipated to increase to $123 million by 2030, with projections indicating growth to around $181 million by 2035.
Global Pterygoid Implants Market Outlook
Revenue, 2025
Forecast, 2035
CAGR, 2026 - 2035
The Pterygoid Implants industry revenue is expected to be around $84.4 million in 2026 and expected to showcase growth with 7.9% CAGR between 2026 and 2035. Clinicians are increasingly turning to graftless Pterygoid Implants to treat significant bone loss in the upper jaw. This trend underscores the value of this method as an alternative to time consuming procedures. These include a bone graft and the elevation of the sinus. Applications of Pterygoid Implants are heavily reliant on the Maxillary Atrophy and Sinus Bypass procedures. These two procedures make up 85.9% of all Pterygoid Implants applications. This is due to the increasing number of elderly and toothless patients. In its 2025 product mix, the company sold 30 50 mm Pterygoid Implants totaling $52.17 million. This popularity of longer implants shows that practitioners prefer using the implants in dense pterygoid bone for added primary stability during complex maxillary rehabilitation. The increased clinical trials, the introduction of computer aided planning in treatment and the growing use of Pterygoid Implants by oral and maxillofacial surgeons, has helped to establish a niche for Pterygoid Implants in the dental implants sector.
In particular, Pterygoid Implants are long lasting implants that integrate into the bone structure of the facial region known as the pterygoid. Their use is best suited to a partial dentures stabilisation in the upper jaw where the bone is weak. By placing these dental implants in the lower region of the eye socket, the need for the sinus lift surgery and for the dental bone graft can be avoided. These implants provide strong anchorage with a 30 to 50 mm length, mechanical stability and bicortical fixation. This allows immediate loading and the predictable replacement of a full jaw in severely resorbed jaw cases. Applications of this technique primarily involve managing sinus bypass and maxillary atrophy. Often the technique is combined with the use of zygomatic implants and regular dental implants to offer fixed, graftless prosthetic solutions in cases where there are implants in the back of the upper jaw that are contraindicated. Growing interest in advanced technologies, such as computer assisted surgery and cone beam CT imaging, is bringing about precise treatment planning and reduced chair times for dental implants in specialist clinics and hospitals.
Market Key Insights
The Pterygoid Implants market is projected to grow from $84.4 million in 2025 to $181 million in 2035. This represents a CAGR of 7.9%, reflecting rising demand across Maxillary Atrophy, Sinus Bypass, and Full Arch Rehabilitation.
The market for dental implants is dominated by a limited number of firms, specifically six major firms. These are led by Southern Implants and Noris Medical who command the largest market share.
In terms of geography, the Pterygoid Implants market was led by USA and Germany together, who were forecast to witness a growth in Compound Annual Growth Rate of 5.1 7.6% during 2025 2030.
Markets such as Brazil, the UAE and South Korea will grow at the fastest rate, estimated at 9.1 10.9% CAGR.
The market for Pterygoid Implants is undergoing significant development driven by factors including a shift towards computer assisted surgical technologies. The changes will create a positive cycle that will lead to an increase in value of approximately $5 million between 2026 and 2030.
The pterygoid implants industry is anticipated to grow by $96.1 million between 2025 and 2035. With a focus on sinus bypass and full arch rehabilitation applications, manufacturers expect to increase their market share.
Due to a rapid increase in dental condition incidence and the acceleration of technology development in dental treatment techniques, demand for pterygoid implants will be 114% greater in 2035 compared with 2025.
Opportunities in the Pterygoid Implants
Growth Opportunities in North America and Asia-Pacific
Market Dynamics and Supply Chain
Driver: Increasing Prevalence of Edentulism Combined with Rising Demand for Graft‑Free Implant Solutions
Restraint: Complex Surgical Technique and Limited Clinician Expertise Hindering Widespread Adoption
Opportunity: Rising demand for Pterygoid Implants from dental tourism patients in Latin American clinics and Expanding Pterygoid Implants use for severe maxillary atrophy in elderly European patients
Challenge: Higher Procedure Costs and Limited Reimbursement Options Restrict Patient Access
Supply Chain Landscape
Biomaterial Sourcing
Pterygoid Implants Manufacturing
Dental Implant Distribution
Clinical End Use
Biomaterial Sourcing
Pterygoid Implants Manufacturing
Dental Implant Distribution
Clinical End Use
Use Cases of Pterygoid Implants in Maxillary Atrophy & Sinus Bypass
Recent Developments
Recent developments in the pterygoid implants market highlight growing use of digital implant planning, 3D printed custom fixtures, and immediate loading protocols to address maxillary atrophy and sinus bypass challenges. A key trend is the adoption of CAD/CAM‑based surgical guides and cone‑beam CT imaging, improving placement accuracy and reducing complications. Major mini dental implant manufacturers are integrating patient‑specific implant solutions and advanced prosthetic rehabilitation systems, enhancing clinician confidence and expanding indications for full arch rehabilitation in atrophic jaws.